Titan Pharmaceuticals, Inc.(NASDAQ : TTNP)
(
)
TTNP PreMarket:
$
()
as of AM
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Message Boards
...
News
...
Health Technology » Pharmaceuticals Major
Company Profile
Titan Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment of chronic diseases utilizing its long-term, continuous drug delivery platform, ProNeura. Its lead product is Probuphine, a buprenorphine implant for the maintenance treatment of opioid addiction. The company was founded by Louis R. Bucalo on February 7, 1992 and is headquartered in South San Francisco, CA.